Literature DB >> 28390267

Effects of TGFβ1, PDGF-BB, and bFGF, on human corneal fibroblasts proliferation and differentiation during stromal repair.

Patricia Gallego-Muñoz1, Lucía Ibares-Frías2, María Cruz Valsero-Blanco3, Roberto Cantalapiedra-Rodriguez4, Jesús Merayo-Lloves5, M Carmen Martínez-García4.   

Abstract

In an effort to improve the regenerative nature of corneal repair, this study reports the use of an in vitro human corneal fibroblasts (HCFs) wound model after treatment with three of the main growth factors (GFs) involved in corneal healing: transforming growth factor beta 1 (TGFβ1), platelet-derived growth factor BB-isoform (PDGF-BB), and basic fibroblast growth factor (bFGF) in order to delve in cell proliferation and differentiation processes. HCFs were mechanically wounded. The individual effect of TGFβ1, PDGF-BB, and bFGF on cell proliferation and differentiation during the repair process was studied at different time points until wound closure. Wound dimensions and morphological changes were evaluated by microscopy. Cell proliferation and myofibroblast differentiation were analyzed by immunofluorescence cytochemistry. Changes in cell morphology were apparent at Day 4. PDGF-BB- and bFGF-treated cells had fibroblast-like morphology. TGFβ1 stimulated proliferation in the wound edge and surrounding area, induced myofibroblast differentiation and inhibited cellular migration. PDGF-BB induced rapid wound closure due to proliferation, high motility, and late myofibroblast differentiation. The time course of closure induced by bFGF was similar to that for PDGF-BB, but was mostly due to proliferation in the wound area, and inhibited myofibroblast differentiation. Each of the GFs induced increases in responses promoting stromal repair differently. This study provides insight regarding how to optimize the outcome of stromal repair following corneal injury.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basic fibroblast growth factor (bFGF); Corneal stroma repair; Human corneal fibroblasts; Myofibroblasts, transforming growth factor beta 1 (TGFβ1); Platelet–derived growth factor BB-isoform (PDGF-BB)

Mesh:

Substances:

Year:  2017        PMID: 28390267     DOI: 10.1016/j.cyto.2017.03.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  18 in total

1.  A proof of concept gene-activated titanium surface for oral implantology applications.

Authors:  Noah Z Laird; Walla I Malkawi; Jaidev L Chakka; Timothy M Acri; Satheesh Elangovan; Aliasger K Salem
Journal:  J Tissue Eng Regen Med       Date:  2020-03-04       Impact factor: 3.963

Review 2.  Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.

Authors:  David M Dolivo
Journal:  J Mol Med (Berl)       Date:  2022-04-28       Impact factor: 4.599

Review 3.  Fallopian tubal infertility: the result of Chlamydia trachomatis-induced fallopian tubal fibrosis.

Authors:  Hua Ling; Lipei Luo; Xingui Dai; Hongliang Chen
Journal:  Mol Cell Biochem       Date:  2021-10-15       Impact factor: 3.396

4.  Synoviocyte-Derived Extracellular Matrix and bFGF Speed Human Chondrocyte Proliferation While Maintaining Differentiation Potential.

Authors:  Rachel D Truong; Megan A Bernier; James E Dennis; Thomas J Kean
Journal:  Front Bioeng Biotechnol       Date:  2022-05-24

5.  Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury.

Authors:  Luciana Lassance; Gustavo K Marino; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Exp Eye Res       Date:  2018-02-24       Impact factor: 3.467

Review 6.  Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

7.  Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.

Authors:  Zhaobo Fan; Zhaobin Xu; Hong Niu; Yang Sui; Haichang Li; Jianjie Ma; Jianjun Guan
Journal:  J Control Release       Date:  2019-09-12       Impact factor: 9.776

8.  Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo.

Authors:  Kaylene Carter; Hyun Jong Lee; Kyung-Sun Na; Gabriella Maria Fernandes-Cunha; Ignacio Jesus Blanco; Ali Djalilian; David Myung
Journal:  Acta Biomater       Date:  2019-09-17       Impact factor: 8.947

9.  Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts.

Authors:  Tácia Tavares Aquinas Liguori; Gabriel Romero Liguori; Luiz Felipe Pinho Moreira; Martin Conrad Harmsen
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

10.  Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling .

Authors:  Flaminia Chellini; Alessia Tani; Larissa Vallone; Daniele Nosi; Paola Pavan; Franco Bambi; Sandra Zecchi Orlandini; Chiara Sassoli
Journal:  Cells       Date:  2018-09-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.